Published in Menopause on March 01, 2010
Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause (2012) 3.32
Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology (2012) 1.96
Premature menopause or early menopause and risk of ischemic stroke. Menopause (2012) 1.84
Awareness and experience of menopausal symptom and hormone therapy in korean postmenopausal women. J Menopausal Med (2014) 1.59
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause (2014) 1.50
The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol (2013) 1.48
Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial. Menopause (2011) 1.40
Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009. Menopause (2011) 1.31
Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol (2011) 1.03
Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol (2012) 1.00
The treatment of climacteric symptoms. Dtsch Arztebl Int (2012) 0.98
Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology (2011) 0.94
Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric (2013) 0.91
Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models. Molecules (2010) 0.90
For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone (2012) 0.90
A measurement-specific quality-of-life satisfaction during premenopause, perimenopause and postmenopause in Arabian Qatari women. J Midlife Health (2014) 0.89
The TU-025 keishibukuryogan clinical trial for hot flash management in postmenopausal women: results and lessons for future research. Menopause (2011) 0.89
Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric (2015) 0.88
Bioidentical hormone therapy. Mayo Clin Proc (2011) 0.88
Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Ann Epidemiol (2014) 0.87
Metabolic disorders in menopause. Prz Menopauzalny (2015) 0.85
Gonadal hormones and cognitive aging: a midlife perspective. Womens Health (Lond Engl) (2011) 0.84
Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study. BMC Womens Health (2011) 0.84
Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Womens Health (2015) 0.84
Cardiovascular disease and primary ovarian insufficiency. Semin Reprod Med (2011) 0.84
Breast cancer survivorship issues. Hematol Oncol Clin North Am (2013) 0.82
Menopausal symptoms and physical activity in multiethnic groups of midlife women: a secondary analysis. J Adv Nurs (2012) 0.81
Hippocampal responsiveness to 17β-estradiol and equol after long-term ovariectomy: implication for a therapeutic window of opportunity. Brain Res (2011) 0.81
Physical activity, hormone replacement therapy, and the presence of coronary calcium in midlife women. Women Health (2012) 0.81
Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions. Endocrinol Metab Clin North Am (2011) 0.80
Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int (2010) 0.80
Defining bioidentical hormones for menopause-related symptoms. Pharm Pract (Granada) (2011) 0.80
Influence of lifestyle factors on breast cancer risk. Breast Care (Basel) (2014) 0.80
Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats. Br J Pharmacol (2012) 0.78
Effect of estrogen on molecular and functional characteristics of the rodent vaginal muscularis. J Sex Med (2013) 0.77
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy. Int J Womens Health (2012) 0.77
The effect of dietary soy isoflavones before and after ovariectomy on hippocampal protein markers of mitochondrial bioenergetics and antioxidant activity in female monkeys. Brain Res (2011) 0.77
Identifying the educational needs of menopausal women: a feasibility study. Womens Health Issues (2010) 0.77
Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States. Ophthalmology (2016) 0.77
Modulation of higher-primate adrenal androgen secretion with estrogen-alone or estrogen-plus-progesterone intervention. Menopause (2013) 0.76
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine. Int J Womens Health (2012) 0.76
Coordinate and synergistic effects of extensive treadmill exercise and ovariectomy on articular cartilage degeneration. BMC Musculoskelet Disord (2016) 0.76
Research resource: Aorta- and liver-specific ERα-binding patterns and gene regulation by estrogen. Mol Endocrinol (2014) 0.76
Bioidentical hormone therapy: Nova Scotia pharmacists' knowledge and beliefs. Pharm Pract (Granada) (2012) 0.75
Cardiopulmonary effects of traditional Thai dance on menopausal women: a randomized controlled trial. J Phys Ther Sci (2015) 0.75
Practice spotlight: pharmacist practice in an outpatient menopause clinic. Can J Hosp Pharm (2012) 0.75
Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan. Osteoporos Int (2014) 0.75
A Rich-Club Organization in Brain Ischemia Protein Interaction Network. Sci Rep (2015) 0.75
Soy consumption during menopause. Facts Views Vis Obgyn (2012) 0.75
Acupuncture as prophylaxis for menstrual-related migraine: study protocol for a multicenter randomized controlled trial. Trials (2013) 0.75
ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells. PLoS One (2016) 0.75
Revisiting estrogen: efficacy and safety for postmenopausal bone health. J Osteoporos (2010) 0.75
Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and Effectiveness. Nutrients (2017) 0.75
Vaginal Estrogen Therapy for Patients with Breast Cancer. Geburtshilfe Frauenheilkd (2013) 0.75
Update on alternative therapies for vulvovaginal atrophy. Patient Prefer Adherence (2011) 0.75
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab (2010) 2.28
Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause (2004) 2.11
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause (2004) 1.57
The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause (2007) 1.51
Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society. Menopause (2003) 1.44
Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause (2006) 1.30
The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65. Menopause (2015) 1.20
The North American Menopause Society: from abstract to publication. Menopause (2008) 1.12
The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause (2011) 1.09
The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause (2006) 1.03
Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause (2003) 1.02
The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause (2005) 0.98
Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. Menopause (2003) 0.90
The role of calcium in peri- and postmenopausal women: consensus opinion of The North American Menopause Society. Menopause (2001) 0.79
In reply. Menopause (2013) 0.75
Thomas B. Clarkson Jr, DVM (June 13, 1931–December 1, 2015). Menopause (2016) 0.75
Patient handout: What you should know about your reproductive time span. Menopause (2014) 0.75